tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS

Aclaris Therapeutics (ACRS) Similar Stocks

Compare
751 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Aclaris Therapeutics
$1.42
$153.76M
25.66%
5 Buy
0 Hold
0 Sell
Strong Buy
Protara Therapeutics
$2.98
$114.97M
23.65%
4 Buy
0 Hold
0 Sell
Strong Buy
Innate Pharma
$1.90
$173.77M
-5.94%
2 Buy
0 Hold
0 Sell
Moderate Buy
4D Molecular Therapeutics
$4.09
$189.47M
-81.91%
5 Buy
0 Hold
1 Sell
Moderate Buy
TriSalus Life Sciences
$5.38
$203.57M
-5.94%
7 Buy
0 Hold
0 Sell
Strong Buy
Molecular Partners
$3.82
$153.31M
-65.30%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACRS
Aclaris Therapeutics
1.42
0.27
23.48%
TARA
Protara Therapeutics
2.98
0.72
31.86%
IPHA
Innate Pharma
1.90
-0.24
-11.21%
FDMT
4D Molecular Therapeutics
4.09
-18.85
-82.17%
TLSI
TriSalus Life Sciences
5.38
-0.31
-5.45%
MOLN
Molecular Partners
3.82
-5.78
-60.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis